About
Peptide for cancer
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyNorway
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
66
By Phase
PHASE1/PHASE2: 2
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05383170Lead Sponsor
A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers
PHASE1/PHASE2Completed
6 participants
Started: Mar 21, 2023 · Completed: Sep 23, 2024
NCT04260529Lead Sponsor
CyPep-1 Injections in Cancer Inducing Lymphocyte Infiltrate Accumulations
PHASE1/PHASE2Completed
60 participants
Started: Apr 30, 2020 · Completed: Jul 5, 2024
Locations (1)
Headquarters
Bergen, Norway
Map
Loading map...